CGNX vs. MKSI, ST, COHR, BMI, ITRI, OSIS, MLAB, DAKT, VPG, and FARO
Should you be buying Cognex stock or one of its competitors? The main competitors of Cognex include MKS Instruments (MKSI), Sensata Technologies (ST), Coherent (COHR), Badger Meter (BMI), Itron (ITRI), OSI Systems (OSIS), Mesa Laboratories (MLAB), Daktronics (DAKT), Vishay Precision Group (VPG), and FARO Technologies (FARO).
Cognex (NASDAQ:CGNX) and MKS Instruments (NASDAQ:MKSI) are both mid-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends.
Cognex has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, MKS Instruments has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500.
In the previous week, MKS Instruments had 6 more articles in the media than Cognex. MarketBeat recorded 12 mentions for MKS Instruments and 6 mentions for Cognex. Cognex's average media sentiment score of 1.48 beat MKS Instruments' score of 0.69 indicating that Cognex is being referred to more favorably in the media.
Cognex has a net margin of 11.76% compared to MKS Instruments' net margin of -48.24%. MKS Instruments' return on equity of 13.90% beat Cognex's return on equity.
88.1% of Cognex shares are owned by institutional investors. Comparatively, 99.8% of MKS Instruments shares are owned by institutional investors. 1.3% of Cognex shares are owned by insiders. Comparatively, 0.5% of MKS Instruments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Cognex presently has a consensus price target of $49.15, indicating a potential upside of 13.83%. MKS Instruments has a consensus price target of $141.25, indicating a potential upside of 7.51%. Given Cognex's higher probable upside, equities research analysts plainly believe Cognex is more favorable than MKS Instruments.
Cognex has higher earnings, but lower revenue than MKS Instruments. MKS Instruments is trading at a lower price-to-earnings ratio than Cognex, indicating that it is currently the more affordable of the two stocks.
Cognex pays an annual dividend of $0.30 per share and has a dividend yield of 0.7%. MKS Instruments pays an annual dividend of $0.88 per share and has a dividend yield of 0.7%. Cognex pays out 51.7% of its earnings in the form of a dividend. MKS Instruments pays out -3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
MKS Instruments received 21 more outperform votes than Cognex when rated by MarketBeat users. Likewise, 71.77% of users gave MKS Instruments an outperform vote while only 60.57% of users gave Cognex an outperform vote.
Summary
Cognex beats MKS Instruments on 12 of the 21 factors compared between the two stocks.
Get Cognex News Delivered to You Automatically
Sign up to receive the latest news and ratings for CGNX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CGNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
